scholarly article | Q13442814 |
P2093 | author name string | Zhigang Hong | |
Neeta Adhikari | |||
Ami Mariash | |||
Marjorie Carlson | |||
Jennifer L. Hall | |||
Sureni Mullegama | |||
Ute Lehman | |||
David L. Basi | |||
Edward K. Weir | |||
P2860 | cites work | Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults | Q22250879 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats | Q28565932 | ||
Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN | Q28566493 | ||
Temporal changes in vascular reactivity in early diabetes mellitus in rats: role of changes in endothelial factors and in phosphodiesterase activity | Q29347153 | ||
Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells | Q30461802 | ||
Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. | Q30827843 | ||
Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. | Q33197914 | ||
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. | Q35605118 | ||
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus | Q35894298 | ||
G protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia | Q36385637 | ||
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials | Q36529261 | ||
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. | Q36600524 | ||
p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice. | Q36638961 | ||
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. | Q36883079 | ||
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus | Q37239783 | ||
Essential role of TGF-beta signaling in glucose-induced cell hypertrophy | Q37292388 | ||
Increased atherosclerosis in streptozotocin-induced diabetic mice | Q37353969 | ||
Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia | Q37362121 | ||
Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase | Q37419190 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Extracellular matrix alterations in hypertensive vascular remodeling | Q37616705 | ||
Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis | Q37643127 | ||
Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study | Q40788011 | ||
Elastin haploinsufficiency results in progressive aortic valve malformation and latent valve disease in a mouse model | Q42470985 | ||
Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus | Q43255708 | ||
Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels | Q43566166 | ||
Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta | Q43596041 | ||
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin | Q43606088 | ||
A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling | Q43893189 | ||
Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work | Q44416767 | ||
Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study | Q44745070 | ||
Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study | Q44895725 | ||
Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction | Q46675986 | ||
Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta | Q46905656 | ||
Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status | Q46967297 | ||
SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis | Q48066756 | ||
Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid. | Q50471471 | ||
Increased levels of acute-phase serum proteins in diabetes. | Q51618740 | ||
Extracellular matrix fibronectin mechanically couples skeletal muscle contraction with local vasodilation. | Q51793183 | ||
Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. | Q53980132 | ||
Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque | Q56986751 | ||
Alterations of elastin and elastase-like activities in aortae of diabetic rats | Q67968589 | ||
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II | Q68883270 | ||
Hyperglycemia results in an increase in myocardial interstitial glucose and glucose uptake during ischemia | Q71061245 | ||
Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM | Q71442189 | ||
Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow | Q72406593 | ||
Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway | Q73015371 | ||
A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia | Q73098115 | ||
Haptoglobin determination in diagnosis of haemolytic diseases | Q77154281 | ||
Isolation of vascular smooth muscle cells from a single murine aorta | Q78675064 | ||
Serum hatoglobin; methodological and clinical studies | Q78677287 | ||
Familial hypohaptoglobinemia. A genetically determined trait segragating from glucose-6-phosphate dehydrogenase deficiency | Q79497262 | ||
Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings | Q79879139 | ||
Femoral artery neointimal hyperplasia is reduced after wire injury in Ref-1+/- mice | Q80174855 | ||
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes | Q81505004 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vasoconstriction | Q1067506 |
P304 | page(s) | 86-94 | |
P577 | publication date | 2010-10-14 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injury | |
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury | |||
P478 | volume | 31 |
Q59335434 | "Liquid Biopsy" of White Matter Hyperintensity in Functionally Normal Elders |
Q37666671 | 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis |
Q35977945 | Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: Role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake |
Q37656600 | Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner |
Q36199128 | Diabetic vascular disease and the potential role of macrophage glucose metabolism |
Q36899626 | Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells |
Q53214972 | Functional polymorphism rs710218 in the gene coding GLUT1 protein is associated with in-stent restenosis. |
Q53378430 | Glucose stimulates chondrocyte differentiation of vascular smooth muscle cells and calcification: A possible role for IL-1β. |
Q36955142 | Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway |
Q38369098 | Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes |
Q27011696 | Insulin resistance, hyperglycemia, and atherosclerosis |
Q64912957 | Localization of Glucose Transporter 10 to Hair Cells' Cuticular Plate in the Mouse Inner Ear. |
Q34616393 | Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta |
Q26849304 | Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier |
Q89013999 | Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome |
Q33612986 | Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis |
Q30359245 | Vascular biomechanical properties in mice with smooth muscle specific deletion of Ndst1 |
Search more.